fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. To gain insights into protective b-glucan epitope(s) and protection mechanisms, we studied two anti-b-glucan monoclonal antibodies (mAb) with identical complementarity-determining regions but different isotypes (mAb 2G8, IgG2b and mAb 1E12, IgM). C. albicans, the most relevant fungal pathogen for humans, was used as a model. Both mAbs bound to fungal cell surface and to the b1,3-b1,6 glucan of the fungal cell wall skeleton, as shown by immunofluorescence, electron-microscopy and ELISA. They were also equally unable to opsonize fungal cells in a J774 macrophage phagocytosis and killing assay. However, only the IgG2b conferred substantial protection against mucosal and systemic candidiasis in passive vaccination experiments in rodents. Competition ELISA and microarray analyses using sequence-defined glucan oligosaccharides showed that the protective IgG2b selectively bound to b1,3-linked (laminarin-like) glucose sequences whereas the nonprotective IgM bound to b1,6- and b1,4-linked glucose sequences in addition to b1,3-linked ones. Only the protective IgG2b recognized heterogeneous, polydisperse high molecular weight cell wall and secretory components of the fungus, two of which were identified as the GPI-anchored cell wall proteins Als3 and Hyr1. In addition, only the IgG2b inhibited in vitro two critical virulence attributes of the fungus, hyphal growth and adherence to human epithelial cells. Our study demonstrates that the isotype of anti-b-glucan antibodies may affect details of the b-glucan epitopes recognized, and this may be associated with a differing ability to inhibit virulence attributes of the fungus and confer protection in vivo. Our data also suggest that the anti-virulence properties of the IgG2b mAb may be linked to its capacity to recognize b-glucan epitope(s) on some cell wall components that exert critical functions in fungal cell wall structure and adherence to host cells. Citation: Torosantucci A
Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence / Torosantucci, A; Chiani, P; Bromuro, C; DE BERNARDIS, F; Palma, As; Liu, Y; Mignogna, Giuseppina; Maras, Bruno; Colone, M; Stringaro, A; Zamboni, S; Feizi, T; Cassone, A.. - In: PLOS ONE. - ISSN 1932-6203. - 4(4):(2009), pp. 1-17. [10.1371/journal.pone.0005392]
Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
MIGNOGNA, Giuseppina;MARAS, Bruno;
2009
Abstract
fungal pathogens such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans. To gain insights into protective b-glucan epitope(s) and protection mechanisms, we studied two anti-b-glucan monoclonal antibodies (mAb) with identical complementarity-determining regions but different isotypes (mAb 2G8, IgG2b and mAb 1E12, IgM). C. albicans, the most relevant fungal pathogen for humans, was used as a model. Both mAbs bound to fungal cell surface and to the b1,3-b1,6 glucan of the fungal cell wall skeleton, as shown by immunofluorescence, electron-microscopy and ELISA. They were also equally unable to opsonize fungal cells in a J774 macrophage phagocytosis and killing assay. However, only the IgG2b conferred substantial protection against mucosal and systemic candidiasis in passive vaccination experiments in rodents. Competition ELISA and microarray analyses using sequence-defined glucan oligosaccharides showed that the protective IgG2b selectively bound to b1,3-linked (laminarin-like) glucose sequences whereas the nonprotective IgM bound to b1,6- and b1,4-linked glucose sequences in addition to b1,3-linked ones. Only the protective IgG2b recognized heterogeneous, polydisperse high molecular weight cell wall and secretory components of the fungus, two of which were identified as the GPI-anchored cell wall proteins Als3 and Hyr1. In addition, only the IgG2b inhibited in vitro two critical virulence attributes of the fungus, hyphal growth and adherence to human epithelial cells. Our study demonstrates that the isotype of anti-b-glucan antibodies may affect details of the b-glucan epitopes recognized, and this may be associated with a differing ability to inhibit virulence attributes of the fungus and confer protection in vivo. Our data also suggest that the anti-virulence properties of the IgG2b mAb may be linked to its capacity to recognize b-glucan epitope(s) on some cell wall components that exert critical functions in fungal cell wall structure and adherence to host cells. Citation: Torosantucci AI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
